A
Allarity Therapeutics D
D
ALLR
1.29000
USD
0.02
(1.57%)
Market Closed
Volume
2,935
EPS
0
Div Yield
-
P/E
0
Market Cap
5,719,327
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Allarity Therapeutics Inc
Sector: Healthcare
Industry: Biotechnology
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.